If you’ve ever had a cholesterol check, you probably know your LDL, HDL, and triglycerides. But there’s a good chance your standard lipid panel never measured lipoprotein(a) — and a major 2026 update to the heart-health guidelines says that’s a gap worth closing for every adult.
In March 2026, the American College of Cardiology and American Heart Association, together with nine other medical organizations, released updated dyslipidemia guidelines. For the first time, they recommended that every adult get a lipoprotein(a) blood test at least once in their lifetime — a Class 1 recommendation, the strongest endorsement a guideline can give. This article explains what the lipoprotein(a) test is, what Lp(a) does in the body, and what results mean.
Note: This article is educational. A lab result is a starting point for a conversation, not a diagnosis — talk to your doctor or clinician about what your results mean for you.
What Is Lipoprotein(a)?
Lipoprotein(a) — written Lp(a) and often pronounced “L-P-little-a” — is a blood particle that looks a lot like LDL (“bad”) cholesterol, with one important difference: it carries an extra protein called apolipoprotein(a).
That extra protein changes how the particle behaves: it resembles plasminogen, a protein involved in breaking down blood clots, but can’t perform that job — so Lp(a) may interfere with normal clot breakdown. Researchers describe the particle as pro-atherogenic (it contributes to artery-clogging plaque), pro-inflammatory, and anti-fibrinolytic (it works against clot dissolution). Evidence from epidemiology and genetics studies supports Lp(a) as a causal contributor to atherosclerotic cardiovascular disease — not just a marker — and to calcific aortic valve stenosis.
Here’s the part that surprises most people: your Lp(a) level is roughly 90% determined by your genes and essentially set for life. Diet doesn’t move it meaningfully. Exercise doesn’t move it. Statins sharply reduce LDL cholesterol but leave Lp(a) largely untouched. About one in five people worldwide has elevated Lp(a) — and most have never been tested, because it was never part of the standard panel.
Why the 2026 Guidelines Changed
Until March 2026, no major U.S. guideline recommended universal Lp(a) screening. Lp(a) was listed as a “risk enhancer” — something clinicians might consider — but not something every adult was urged to measure.
The 2026 ACC/AHA multisociety Guideline on the Management of Dyslipidemia (published in JACC and Circulation) changed that, recommending Lp(a) measurement at least once in all adults. Two facts drove the shift:
- The risk is large and common. Elevated Lp(a) — 125 nmol/L or greater — is linked to roughly a 40% increase in long-term risk of heart attack or stroke. Risk rises further with higher values: at about 250 nmol/L, long-term risk roughly doubles, and at 350 nmol/L it roughly triples.
- One test covers a lifetime. Because Lp(a) barely changes over time, a single adult measurement informs your risk profile for decades. It can also change treatment decisions: people with high Lp(a) may benefit from more intensive management of their other risk factors (for example, statin therapy even when LDL cholesterol looks normal).
Notably, testing rates before the guideline change were tiny — one analysis of nearly 600,000 U.S. patients with cardiovascular disease found only 0.4% had ever had an Lp(a) test.
What the Lipoprotein(a) Test Measures (and How It’s Reported)
The lipoprotein(a) test is a simple blood draw with no special preparation — Lp(a) isn’t affected by meals, so fasting typically isn’t required.
There is one important reporting quirk to know. Lp(a) can be reported in two different units:
- nmol/L (nanomoles per liter) — measures particle concentration
- mg/dL (milligrams per deciliter) — measures mass concentration
The guideline threshold for “high” is ≥125 nmol/L or ≥50 mg/dL. These two numbers are not interchangeable, and labs and clinicians caution against converting between them, because the apolipoprotein(a) protein comes in different sizes from person to person, which skews mass-based measurement. When you get a result, note which unit your lab used.
Common result ranges
|
Result |
What it suggests |
|---|---|
|
<30 mg/dL (<75 nmol/L) |
Low Lp(a); not considered an added risk factor |
|
30–50 mg/dL (75–125 nmol/L) |
Intermediate; a risk modifier worth watching |
|
≥50 mg/dL (≥125 nmol/L) |
Elevated; a risk enhancer that may change prevention plans |
Risk rises continuously rather than at a single cut-off, so higher numbers carry more weight than just being “above the line.”
What an Elevated Lp(a) Result Means
An elevated Lp(a) result means you carry a lifelong genetic predisposition to higher cardiovascular risk. It does not mean you will have a heart attack, and it doesn’t indicate active disease. There are currently no approved medications that specifically lower Lp(a) (several are in clinical trials), so the value of knowing is about what you do with everything else:
- Tighter control of modifiable risks. LDL cholesterol, blood pressure, blood sugar, and smoking all add to overall risk — each one that’s well controlled counts for more when baseline risk is higher.
- A more complete risk conversation. Your clinician can integrate Lp(a) into risk tools like the PREVENT calculator (which replaced the older Pooled Cohort Equations in the 2026 guideline update) for a more accurate 10- and 30-year risk estimate.
- Family awareness. Lp(a) is inherited, so an elevated result is a signal for close relatives to get tested too.
A single lifetime measurement is considered sufficient because levels are stable — though your clinician may re-test if the first sample was drawn during pregnancy or an acute illness.
Why Your Standard Lipid Panel Misses It
A routine lipid panel reports total cholesterol, LDL-C, HDL-C, and triglycerides — Lp(a) is not included; your clinician has to order it specifically. If you’ve ever been told your cholesterol was “fine” but still worry about family history of heart disease, Lp(a) testing can fill in the picture — ask your clinician whether a one-time test makes sense for you. Direct-to-consumer labs such as HealthOneLabs can also offer Lp(a) testing without a doctor’s referral.
Frequently Asked Questions
How is Lp(a) different from LDL cholesterol?
LDL-C is the “bad cholesterol” on standard panels and responds to diet, exercise, and statins. Lp(a) is an LDL-like particle with an extra protein that makes it stickier and more inflammatory; it’s ~90% genetically determined and essentially fixed for life. High Lp(a) raises heart attack and stroke risk independently of LDL-C.
Do I need to fast before a lipoprotein(a) test?
No. Lp(a) levels aren’t meaningfully affected by food, so fasting is generally not required. Check your lab’s instructions anyway, since Lp(a) is often ordered alongside other tests that might need fasting.
What should I do if my Lp(a) is high?
Discuss it with your clinician. There’s no approved drug that lowers Lp(a) yet, so the strategy is usually aggressive management of the risk factors you can change — LDL cholesterol, blood pressure, blood sugar, and not smoking. Family members may want testing too, since Lp(a) is inherited.
If my Lp(a) is normal, do I need to retest?
Generally no. Because Lp(a) is genetically set and stable across adulthood, one lifetime measurement is considered sufficient — a major reason the 2026 guideline made it a one-time recommendation for all adults.
Sources: 2026 ACC/AHA multisociety Guideline on the Management of Dyslipidemia (JACC/Circulation, March 2026); Harvard Health summary of the guideline (April 2026). Educational purposes only — not medical advice.